Goldman Sachs Group Inc Compass Pathways PLC Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	N/A	29,550 Added 122.94%	53,587 $457,000
Q3 2023 May 14, 2024	SELL	N/A	-29,550 Reduced 55.14%	24,037 $205,000
Q3 2023 Nov 14, 2023	BUY	N/A	24,037 New	24,037 $205,000
Q3 2022 May 14, 2024	SELL	$10.73 - $20.07 $330,720 - $618,597	-30,822 Reduced 57.52%	22,765 $244,000
Q3 2022 Nov 10, 2022	BUY	$10.73 - $20.07 $244,268 - $456,893	22,765 New	22,765 $244,000

Q2 2022 Aug 15, 2022	SELL	$6.76 - $14.18 $238,783 - $500,880	-35,323 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.13 - $23.04 $31,943 - $66,124	2,870 Added 8.84%	35,323 $455,000
Q4 2021 Feb 14, 2022	SELL	$21.81 - $48.96 $500,670 - $1.12 Million	-22,956 Reduced 41.43%	32,453 $717,000
Q3 2021 Nov 10, 2021	BUY	$29.03 - $38.62 $1.61 Million - $2.14 Million	55,409 New	55,409 $1.66 Million

133

27.2M

108K

172K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.